Voice your opinion on congressional bill S1785-116 and let lawmakers know your stance with UnPac!

Main Subject: Health

Fair and Accurate Medicaid Pricing Act of 2019 or the Fair AMP Act

This bill alters certain requirements and definitions under the Medicaid Drug Rebate Program relating to rebate calculations. Specifically, the bill repeals the requirement that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand-name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations.

HR4378-116, HR3276-116, S1801-116,

Senate Actions

IntroReferral
Jun. 11 2019	Read twice and referred to the Committee on Finance.

Library of Congress Actions

IntroReferral
Jun. 11 2019	Introduced in Senate

Senate bill S1785-116

Fair AMP Act

Promote the cause!

Or use this QR code